Error: Could not add to watchlist. X

JCL Bioassay Corp

+ Watchlist
2190:JP
Acquired
2190:JP was acquired by 2309:JP
JPY
Volume
0
52Wk Range
360.0 - 582.0
Current P/E Ratio (TTM)
-
Earnings per Share (JPY) (TTM)
28.9
Market Cap (JPY)
-
Shares Outstanding (m)
4.171
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Health Care Facilities & Svcs
Sub-Industry
Health Care Services

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
JCL Bioassay Corporation provides Clinical and Non-Clinical trial services for pharmaceutical companies. The line of business includes chemical analysis such as determination of drug contents in biological matrices and drug product stability tests.
ADDRESS
No.3-5-24 Miyahara
Yodogawa-Ku
Osaka
Japan
PHONE
81-6-6151-6700
  • Kunio Momiyama
    President/Founder
  • Noriko Inoue
    Managing Director
  • Takanobu Yoshida
    Director
Show More